Abnova (Taiwan) Corporation (4133.TW)
Abnova (Taiwan) Corporation engages in the research, development, manufacturing, and sales of monoclonal and multiclonal antibodies, proteins, medical diagnostic instruments, and testing reagents.
21.05+0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-24.8%
The outlook
Abnova (Taiwan) Corporation currently reads as leaning bearish based on mixed vs its moving averages, 11% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendMixed vs its moving averages
52-week range11% of the way from its 52-week low to high
Market cap
$1.27B
52-wk high
29.15
52-wk low
20.00
50-day avg
20.97
200-day avg
22.90
Trailing P/E
526.3